Bionano Genomics, Inc. (BNGO) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $1.00K; Additional Paid in Capital, Common StockUSD $766.94M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $14.00K.
- 2026-03-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $1.00K; Additional Paid in Capital, Common StockUSD $765.37M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $12.00K.
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $1.00K; Additional Paid in Capital, Common StockUSD $764.03M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $17.00K.
- 2025-09-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $1.00K; Additional Paid in Capital, Common StockUSD $761.48M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $6.00K.
Bionano Genomics, Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature USD | Adjustments to Additional Paid in Capital, Warrant Issued USD |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $1.00K | $766.94M | $14.00K | $-735.35M | $31.61M | 3 month · $970.00K | (m) | (m) |
| 2026-03-31 | $0.00 | $1.00K | $765.37M | $12.00K | $-727.92M | $37.46M | 3 month · $670.00K | (m) | (m) |
| 2025-12-31 | $0.00 | $1.00K | $764.03M | $17.00K | $-719.62M | $44.42M | 12 month · $4.53M | (m) | (m) |
| 2025-09-30 | $0.00 | $1.00K | $761.48M | $6.00K | $-711.69M | $49.80M | 3 month · $941.00K | (m) | (m) |
| 2025-06-30 | $0.00 | $0.00 | $748.57M | $-10.00K | $-703.18M | $45.37M | 3 month · $1.08M | (m) | (m) |
| 2025-03-31 | $0.00 | $0.00 | $744.50M | $14.00K | $-696.33M | $48.19M | 3 month · $1.59M | (m) | (m) |
| 2024-12-31 | $0.00 | $0.00 | $728.57M | $27.00K | $-693.23M | $35.38M | 12 month · $9.74M | (m) | (m) |
| 2024-09-30 | $0.00 | $9.00K | $720.42M | $1.53M | $-673.10M | $48.86M | 3 month · $2.20M | (m) | (m) |
| 2024-06-30 | $0.00 | $7.00K | $709.19M | $-3.00K | $-628.85M | $80.33M | 3 month · $2.58M | (m) | (m) |
| 2024-03-31 | $0.00 | $6.00K | $695.41M | $-16.00K | $-612.63M | $82.77M | 3 month · $3.02M | (m) | (m) |
| 2023-12-31 | $0.00 | $0.00 | $677.34M | $23.00K | $-581.21M | $96.16M | 12 month · $15.18M | (m) | (m) |
| 2023-09-30 | $0.00 | $3.00K | $656.41M | $-93.00K | $-537.32M | $119.00M | 3 month · $3.99M | (m) | (m) |
| 2023-06-30 | $0.00 | $3.00K | $639.81M | $-310.00K | $-424.75M | $214.76M | 3 month · $3.93M | (m) | (m) |
| 2023-03-31 | $0.00 | $31.00K | $617.96M | $-665.00K | $-385.84M | $231.49M | 3 month · $3.88M | (m) | (m) |
| 2022-12-31 | $0.00 | $3.00K | $599.23M | $-1.12M | $-348.71M | $249.40M | 12 month · $22.42M | (m) | (m) |
| 2022-09-30 | $0.00 | $30.00K | $593.57M | $-1.82M | $-310.04M | $281.74M | 3 month · $6.06M | (m) | (m) |
| 2022-06-30 | $0.00 | $29.00K | $564.85M | $-1.92M | $-278.23M | $284.73M | 3 month · $5.78M | (m) | (m) |
| 2022-03-31 | $0.00 | $29.00K | $558.86M | $-1.64M | $-246.07M | $311.19M | 3 month · $5.10M | (m) | (m) |
| 2021-12-31 | $0.00 | $29.00K | $553.75M | $-539.00K | $-216.12M | $337.12M | 12 month · $9.72M | (m) | (m) |
| 2021-09-30 | $0.00 | $28.00K | $534.82M | $-116.00K | $-193.17M | $341.56M | 3 month · $2.79M | (m) | (m) |
| 2021-06-30 | $0.00 | $28.00K | $518.25M | (m) | $-172.42M | $345.87M | 3 month · $1.76M | (m) | (m) |
| 2021-03-31 | $0.00 | $28.00K | $516.32M | (m) | $-153.63M | $362.72M | 3 month · $371.00K | (m) | (m) |
| 2020-12-31 | $0.00 | $19.00K | $178.75M | $0.00 | $-143.68M | $35.08M | 12 month · $1.55M | (m) | (m) |
| 2020-09-30 | (m) | $15.00K | $146.61M | (m) | $-131.95M | $14.68M | 3 month · $447.00K | (m) | (m) |
| 2020-06-30 | (m) | $9.00K | $126.99M | (m) | $-121.16M | $5.84M | 3 month · $328.00K | (m) | (m) |
| 2020-03-31 | (m) | $3.00K | $108.87M | (m) | $-113.09M | $-4.21M | 3 month · $328.00K | (m) | (m) |
| 2019-12-31 | $0.00 | $3.43K | $106.19M | (m) | $-102.58M | $3.61M | 3 month · $357.00K 12 month · $1.35M | 12 month · $201.79K | 12 month · $629.83K |
| 2019-09-30 | (m) | $1.09K | $87.30M | (m) | $-94.68M | $-7.38M | 3 month · $364.00K | (m) | (m) |
| 2019-06-30 | (m) | $1.09K | $86.93M | (m) | $-88.28M | $-1.34M | 3 month · $336.00K | (m) | (m) |
| 2019-03-31 | $0.00 | $1.08K | $86.48M | (m) | $-80.61M | $5.87M | 3 month · $289.00K | 3 month · $202.00K | 3 month · $630.00K |
| 2018-12-31 | $0.00 | $1.00K | $82.90M | (m) | $-72.76M | $10.14M | 12 month · $1.19M | (m) | 12 month · $165.00K |
| 2018-09-30 | $0.00 | $1.00K | $81.58M | (m) | $-66.35M | $15.24M | 3 month · $53.13K 9 month · $160.55K | (m) | (m) |
| 2018-06-30 | (m) | (m) | (m) | (m) | (m) | $-57.28M | 3 month · $52.98K | (m) | (m) |
| 2018-03-31 | (m) | (m) | (m) | (m) | (m) | $-54.02M | 3 month · $54.44K | (m) | (m) |
| 2017-12-31 | $0.00 | $8.00 | $4.04M | (m) | $-54.27M | $-50.23M | 12 month · $382.83K | (m) | (m) |
| 2016-12-31 | (m) | (m) | (m) | (m) | (m) | $-27.26M | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |